DE60134469D1 - Humane epitheliale zellen von müllerian ductus-abstammende, verfahren zur ihrer isolierung und verwendungen davon - Google Patents

Humane epitheliale zellen von müllerian ductus-abstammende, verfahren zur ihrer isolierung und verwendungen davon

Info

Publication number
DE60134469D1
DE60134469D1 DE60134469T DE60134469T DE60134469D1 DE 60134469 D1 DE60134469 D1 DE 60134469D1 DE 60134469 T DE60134469 T DE 60134469T DE 60134469 T DE60134469 T DE 60134469T DE 60134469 D1 DE60134469 D1 DE 60134469D1
Authority
DE
Germany
Prior art keywords
epithelial cells
müllerian
derived epithelial
abstammende
ductus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60134469T
Other languages
German (de)
English (en)
Inventor
Ronghao Li
Jennie Powell Mather
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Raven Biotechnologies Inc
Original Assignee
Raven Biotechnologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Raven Biotechnologies Inc filed Critical Raven Biotechnologies Inc
Application granted granted Critical
Publication of DE60134469D1 publication Critical patent/DE60134469D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0681—Cells of the genital tract; Non-germinal cells from gonads
    • C12N5/0682—Cells of the female genital tract, e.g. endometrium; Non-germinal cells from ovaries, e.g. ovarian follicle cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/20—Transition metals
    • C12N2500/24—Iron; Fe chelators; Transferrin
    • C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/38—Vitamins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE60134469T 2000-04-07 2001-04-04 Humane epitheliale zellen von müllerian ductus-abstammende, verfahren zur ihrer isolierung und verwendungen davon Expired - Lifetime DE60134469D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/545,435 US6416999B1 (en) 2000-04-07 2000-04-07 Human Müllerian duct-derived epithelial cells and methods of isolation and uses thereof
PCT/US2001/010998 WO2001077298A2 (en) 2000-04-07 2001-04-04 Human müllerian duct-derived epithelial cells and methods of isolation and uses thereof

Publications (1)

Publication Number Publication Date
DE60134469D1 true DE60134469D1 (de) 2008-07-31

Family

ID=24176236

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60134469T Expired - Lifetime DE60134469D1 (de) 2000-04-07 2001-04-04 Humane epitheliale zellen von müllerian ductus-abstammende, verfahren zur ihrer isolierung und verwendungen davon

Country Status (11)

Country Link
US (2) US6416999B1 (cg-RX-API-DMAC10.html)
EP (1) EP1276850B1 (cg-RX-API-DMAC10.html)
JP (1) JP4748700B2 (cg-RX-API-DMAC10.html)
KR (1) KR100748039B1 (cg-RX-API-DMAC10.html)
CN (1) CN1423692A (cg-RX-API-DMAC10.html)
AT (1) ATE398671T1 (cg-RX-API-DMAC10.html)
AU (2) AU2001251311B2 (cg-RX-API-DMAC10.html)
CA (1) CA2404634A1 (cg-RX-API-DMAC10.html)
DE (1) DE60134469D1 (cg-RX-API-DMAC10.html)
DK (1) DK1276850T3 (cg-RX-API-DMAC10.html)
WO (1) WO2001077298A2 (cg-RX-API-DMAC10.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6416999B1 (en) * 2000-04-07 2002-07-09 Raven Biotechnologies, Inc. Human Müllerian duct-derived epithelial cells and methods of isolation and uses thereof
CA2475356A1 (en) * 2002-02-12 2003-08-21 Raven Biotechnologies, Inc. Human fetal bladder-derived epithelial cells
KR20050004263A (ko) * 2002-05-30 2005-01-12 레이븐 바이오테크놀로지스, 인코퍼레이티드 독물학 및 투여량 예측을 위한 동물 모델
ATE488530T1 (de) 2002-06-19 2010-12-15 Raven Biotechnologies Inc Internalisierende antikörper spezifisch für das raag10 zelloberflächenziel
WO2004043239A2 (en) * 2002-11-13 2004-05-27 Raven Biotechnologies, Inc. Antigen pipa and antibodies that bind thereto
GEP20135796B (en) 2006-03-07 2013-04-10 Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation
WO2008091908A2 (en) 2007-01-22 2008-07-31 Raven Biotechnologies Human cancer stem cells
EP2464661B1 (en) 2009-08-13 2018-01-17 The Johns Hopkins University Methods of modulating immune function with anti-b7-h7cr antibodies
CN102732479B (zh) * 2011-03-31 2014-08-27 北京大学 胸腺上皮前体细胞的制备方法及其专用培养基
AU2013248265B2 (en) * 2012-11-08 2018-11-01 Viacyte, Inc. Scalable primate pluripotent stem cell aggregate suspension culture and differentiation thereof
CN108061804B (zh) * 2016-11-09 2020-05-12 北京大学人民医院 用于诊断子宫内膜异位症的生物标志物
CN107475369B (zh) * 2017-07-07 2021-05-04 南方医科大学 Hoxa9基因在制备治疗皮肤鳞状细胞癌药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE222598T1 (de) * 1996-04-19 2002-09-15 Nestle Sa Menschliche immortalisierte colon- epithelialzellen
US6004528A (en) 1997-09-18 1999-12-21 Bergstein; Ivan Methods of cancer diagnosis and therapy targeted against the cancer stemline
US6416999B1 (en) 2000-04-07 2002-07-09 Raven Biotechnologies, Inc. Human Müllerian duct-derived epithelial cells and methods of isolation and uses thereof

Also Published As

Publication number Publication date
DK1276850T3 (da) 2008-10-13
CA2404634A1 (en) 2001-10-18
CN1423692A (zh) 2003-06-11
EP1276850A2 (en) 2003-01-22
US7125713B2 (en) 2006-10-24
JP2003530100A (ja) 2003-10-14
AU5131101A (en) 2001-10-23
KR20030032933A (ko) 2003-04-26
WO2001077298A3 (en) 2002-07-04
JP4748700B2 (ja) 2011-08-17
US20030040110A1 (en) 2003-02-27
WO2001077298A2 (en) 2001-10-18
US6416999B1 (en) 2002-07-09
KR100748039B1 (ko) 2007-08-09
EP1276850B1 (en) 2008-06-18
AU2001251311B2 (en) 2005-03-03
ATE398671T1 (de) 2008-07-15

Similar Documents

Publication Publication Date Title
DE60125342D1 (de) Humane pankreatische epitheliale stammzellen, verfahren zur ihrer isolierung und verwendungen davon
ATE398671T1 (de) Humane epitheliale zellen von müllerian ductus- abstammende, verfahren zur ihrer isolierung und verwendungen davon
Maalouf et al. Differential acetylation of histone H4 lysine during development of in vitro fertilized, cloned and parthenogenetically activated bovine embryos
WO2002083864A3 (en) Methods and reagents for cell transplantation
ATE407138T1 (de) Verfahren zur herstellung interferierender rna- moleküle in säugetierzellen und therapeutische anwendungen solcher moleküle
ATE469219T1 (de) Zusammensetzungen, methoden und reagentien zur nukleinsäureisolierung mittels oberflächenaktiven substanzen und proteasen
EP2722387A3 (en) Definitive endoderm
ATE489119T1 (de) Plasmaprotein-matritzes und verfahren zu ihrer herstellung
DE50114426D1 (de) Verfahren zur herstellung gebrauchsfertiger, antigenbeladener oder -unbeladener, kryokonservierter, reifer dendritischer zellen
DE60236396D1 (de) Einkristallines Substrat aus GaN, Verfahren zu ihrer Züchtung und zu ihrer Herstellung
ATE505533T1 (de) Antigenpräsentierende zellen, verfahren zu ihrer herstellung sowie ihre verwendung für krebsimpfstoffe
EP2471906A3 (en) Placental stem cell populations
CN106676075B (zh) 一种孤雌单倍体胚胎干细胞及其制备与应用
AU2002359522A1 (en) Compositions and methods of selective nucleic acid isolation
EP2213741A3 (en) Compositions and methods of using a synthetic DNAse I
WO2005113747A3 (de) Multizelluläre gewebe- und organkultursysteme
IL178305A0 (en) Microelectromechanical devices useful for manipulating cells or embryos, kits thereof, methods of making same, and methods of use thereof
WO2003057849A3 (en) Telomere-encoding synthetic dna nanocircles, and their use for the elongation of telomere repeats
DE60221224D1 (de) Verfahren und vektoren für die plastiden-transformation von höheren pflanzen
AU2002350139A1 (en) Production of cell suspensions
SG144710A1 (en) Tissue array instrument
WO2003010292A3 (en) Methods and apparatus for enrichment and culture of monocytic dendritic cell precursors
ATE521697T1 (de) Verfahren zum wachstum von menschlichen bindehautgewebeäquivalenten für die forschung, die klinische augenoberflächentransplantation und die geweberekonstruktion
WO2004013288A3 (en) Methods and kits for synthesis of sirna expression cassettes
WO2002034887A3 (en) Maturation of dendritic cells

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
R082 Change of representative

Ref document number: 1276850

Country of ref document: EP

Representative=s name: VOSSIUS & PARTNER, 81675 MUENCHEN, DE